ZikaIgM
Laboratory Fee Schedule
Procedure: MAM0089A
CPT: 86790
Synonym(s): | Detection of IgM Antibodies to Zika Virus by Immunochromatographic Assay (ICA), Chembio Dual Path Platform (DPP) Assay System. Rapid point-of-care diagnostic test. |
Requisition Form | G-2V |
Test Description | Qualitative Immunochromatographic Assay (ICA) for the presumptive detection of IgM antibodies to Zika virus using Chembio DPP Assay system.. |
Pre-Approval Needed | N/A |
Supplemental Information Required | N/A |
Supplemental Form(s) | N/A |
Performed on Specimens from (sources) | Human |
Sample/Specimen Type for Testing | Serum |
Minimum Volume/Size Required | 1.0 mL |
Storage/Preservation Prior to Shipping | Serum separated from the clot may be stored at 2°C to 8°C up to 48 hours, but then must be frozen at -20°C or colder until shipped. |
Transport Medium | N/A |
Specimen Labeling | At least 2 patient specific identifiers: First and last name as one identifier and a DOB or a unique patient specific identifier (e.g. Medical Record number); must match information on submission form (G-2A). |
Shipping and Specimen Handling Requirements |
|
Method | ICA, lateral flow test, rapid test |
Turn-around Time | 7 working days |
Interferences/Limitations | Most common cause of false positive results is cross-reactivity with IgM specific for other flaviviruses. |
Common Causes for Rejection | Insufficient quantity, unacceptable specimen type or source, improper shipping conditions, expired media or collection container, discrepancies between specimen label and submission form, and/or incomplete or missing submission form. |
Additional Information | Minimum volume for CDC confirmation testing 0.5 mL. |